Kritoma

Discovery

Explore Topics Papers

Docs Terms Privacy

Search Kritoma

Recent searches

Searches you run from this bar will appear here.

GLP-1 receptor agonists for obesity treatment

Clinical MedicineUpdated Oct 5, 2026Version v1

Knowledge Timeline Gaps (1)Evidence (359)Community (0)

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

359 papers

SearchSort evidence

All359 Core251 Supporting111 Background0

Showing 205-216 of total 359 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2026PubMedSupporting evidence

Efficacy and safety of tofacitinib in ankylosing spondylitis patients: a systematic review and meta-analysis.

Shen L; Han K; Bo L; Huang F

Jan 1, 2026

Clinics (Sao Paulo, Brazil)

2026PubMedDirectly related

Semaglutide and Tirzepatide for the treatment of MASH: What Works, What's Coming, and What's Missing.

Chirapongsathorn S; Tacke F

Jan 1, 2026Digestion

2026PubMedDirectly related

Trends in preoperative weight loss modalities among patients receiving body contouring surgery.

Liang J; Anderson JL; Cathey JM; Zhang J; Yi VN; Patel A

Jan 1, 2026Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery

2026PubMedDirectly related

Association of GLP-1 Receptor Agonists Versus Other Antidiabetic Medications With Cardiovascular, Renal, and Liver Outcomes in Patients With Type 2 Diabetes.

Fan Y; Peng N; Jiang L; Wei R; Lu G; Zhang S; Mu C; Xue M; Lyu B; Yao D

Jan 1, 2026Diabetes, obesity & metabolism

2026PubMedSupporting evidence

GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Trial: Rationale, Design and Baseline Characteristics.

Samuels JM; Williams CR; Patel MB; Self WH; Funk LM; Roumie C; Spann MD; Northup CJ; Ye F; Irlmeier R; Sohn I; Zhu Y; Niswender K

Jan 1, 2026Diabetes, obesity & metabolism

2026PubMedDirectly related

Digital Behavioral Infrastructure for Glucagon-Like Peptide-1 Pharmacotherapy: Viewpoint on Persistence, Tolerability, and Postcessation Durability.

Cook G

Jan 1, 2026Journal of medical Internet research

2026PubMedDirectly related

GLP-1 Receptor Agonists in Dermatology: Ethical Considerations.

Deitelzweig C; Rahim F; Stoff BK

Jan 1, 2026Clinics in dermatology

2026PubMedSupporting evidence

The impact of glucagon-like peptide-1 (GLP-1) receptor agonists on postoperative outcomes following rotator cuff repair.

Choudhury A; Slusarczyk S; Mathson L; Van Boxtel M; LoGiudice A; Hanley J

Jan 1, 2026Shoulder & elbow

2026PubMedDirectly related

Glucagon-Like Peptide-1 Receptor Agonist Use Before and After Liver Transplant.

Manolas MI; Brown RS Jr

Jan 1, 2026Gastroenterology & hepatology

2026PubMedSupporting evidence

Comorbidities in clinical cohorts of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis.

Leong MCH; Green S; Guan M; Walters TM; Marshall E; Sok C; Goh NSL; Ryerson CJ; Khor YH

Jan 1, 2026European respiratory review : an official journal of the European Respiratory Society

2026PubMedSupporting evidence

Monitoring Liraglutide Oligomeric Interconversion and Fibril Dissociation through High-Pressure NMR Spectroscopy.

Xu X; Trigo-Mouriño P; Gao Q; Liang Y; McCoy MA; Reibarkh M

Jan 1, 2026Analytical chemistry

2026PubMedDirectly related

Impact of GLP-1 receptor agonists on patients with intraductal papillary mucinous neoplasms: Study protocol for a multicentric cohort study.

Lagger M; Najberg H; Miftaroski A; Widmer L; Di Renzo S; Iranmanesh P; Matter M; Tekdogan B; Perrodin S; Gloor B; Toso C; Frossard JL; Adamina M; Buhler L

Jan 1, 2026PloS one

Page 18 of 30Showing 205-216 of total 359 results.

1...171819...30

GLP-1 receptor agonists for obesity treatment — Research Evidence and Topic... | Kritoma